Review
Published on 09 May 2024
Stem cell therapies: a new era in the treatment of multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1389697
- 19,740 views
- 10 citations
Type at least 3 characters
1,176 articles
articles
Original Research
Published on 01 May 2024
“A second birthday”? Experiences of persons with multiple sclerosis treated with autologous hematopoietic stem cell transplantation—a qualitative interview study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1384551
- 3,013 views
- 2 citations
Brief Research Report
Published on 01 May 2024
IL-6 receptor antibody treatment improves muscle weakness in experimental autoimmune myasthenia gravis mouse model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1356300
- 4,148 views
- 7 citations
Original Research
Published on 26 Apr 2024
Patterns of multiple sclerosis presentation to the emergency department
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1395822
- 2,571 views
- 3 citations
Case Report
Published on 23 Apr 2024
Case report: Cerebrospinal fluid neutrophilic pleocytosis upon intrathecal triamcinolone injection
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1372266
- 1,991 views
- 2 citations
Original Research
Published on 19 Apr 2024
Practical tool to identify Spasticity-Plus Syndrome amongst patients with multiple sclerosis. Algorithm development based on a conjoint analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1371644
- 2,726 views
- 1 citation
Systematic Review
Published on 18 Apr 2024
Hypogammaglobulinemia and infections in patients with multiple sclerosis treated with anti-CD20 treatments: a systematic review and meta-analysis of 19,139 multiple sclerosis patients
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1380654
- 8,040 views
- 21 citations
Case Report
Published on 18 Apr 2024
Case report: Headache as the sole neurological symptom in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1366263
- 2,635 views
Case Report
Published on 18 Apr 2024
Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection?
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1356691
- 2,153 views
Original Research
Published on 16 Apr 2024
Immunophenotyping in routine clinical practice for predicting treatment response and adverse events in patients with MS
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1388941
- 2,104 views
- 1 citation
Case Report
Published on 16 Apr 2024
Case report: Transition from anti-CD20 therapy to inebilizumab for 14 cases of neuromyelitis optica spectrum disorder
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1352779
- 7,474 views
- 7 citations
Original Research
Published on 10 Apr 2024
People with newly diagnosed multiple sclerosis benefit from a complex preventative intervention—a single group prospective study with follow up
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1373401
- 2,049 views
- 1 citation
Systematic Review
Published on 10 Apr 2024
Risk of secondary immune thrombocytopenia following alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1375615
- 2,639 views
Mini Review
Published on 09 Apr 2024
A rapid review of differences in cerebrospinal neurofilament light levels in clinical subtypes of progressive multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1382468
- 2,570 views
- 2 citations
Original Research
Published on 08 Apr 2024
Primary CNS vasculitis: insights into clinical, neuropathological, and neuroradiological characteristics
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1363985
- 4,615 views
- 1 citation
Study Protocol
Published on 04 Apr 2024
Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1379712
- 3,940 views
- 1 citation
Original Research
Published on 22 Mar 2024
Clinical characteristics and MRI features of autoimmune glial fibrillary acidic protein astrocytopathy: a case series of 34 patients
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1375971
- 8,081 views
- 14 citations
Case Report
Published on 20 Mar 2024
Gait instability, ophthalmoplegia, and chorea with orofacial dyskinesia in a man with anti-Ri antibodies: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1359781
- 2,409 views
- 2 citations
Brief Research Report
Published on 14 Mar 2024
Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1380541
- 3,782 views
- 6 citations
Case Report
Published on 11 Mar 2024
Probable secondary hemophagocytic lymphohistiocytosis manifesting as central nervous system lesions after COVID-19 vaccination: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1363072
- 3,093 views
- 5 citations
Systematic Review
Published on 11 Mar 2024
Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1295770
- 8,263 views
- 12 citations
Case Report
Published on 29 Feb 2024
Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1363493
- 5,632 views
- 2 citations
Original Research
Published on 28 Feb 2024
Prediction of pulmonary infection in patients with severe myelitis by NPAR combined with spinal cord lesion segments
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1364108
- 2,292 views
- 9 citations
Original Research
Published on 28 Feb 2024
Factors affecting driving performance in patients with Multiple Sclerosis – still an open question
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2024.1369143
- 2,874 views
- 2 citations